Schonfeld Strategic Advisors LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 96 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$1,673,000
-29.3%
70,000
-56.8%
0.02%
-34.4%
Q4 2020$2,365,000
-12.6%
161,955
-15.0%
0.03%
-38.5%
Q3 2020$2,707,000
-17.0%
190,623
-14.0%
0.05%
+18.2%
Q2 2020$3,262,000
+709.4%
221,658
+164.2%
0.04%
+340.0%
Q4 2019$403,000
+194.2%
83,900
+272.9%
0.01%
+150.0%
Q3 2019$137,000
-88.5%
22,500
-86.6%
0.00%
-90.2%
Q1 2019$1,187,000
+62.8%
167,400
+11.6%
0.04%
+46.4%
Q4 2018$729,000
-73.6%
150,000
-60.1%
0.03%
-77.2%
Q3 2018$2,763,000
+56.5%
376,000
+35.9%
0.12%
+28.1%
Q2 2018$1,766,000
+8.2%
276,700
-7.8%
0.10%
-21.3%
Q1 2018$1,632,000
+160.7%
300,000
+100.0%
0.12%
+139.2%
Q4 2017$626,000
-69.0%
150,000
-28.6%
0.05%
-72.4%
Q3 2017$2,022,000
-58.5%
210,000
-49.0%
0.18%
-63.1%
Q2 2017$4,869,000
+16.8%
411,600
+26.6%
0.50%
+20.1%
Q1 2017$4,167,000325,0000.42%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,365,000$16,186,0001.49%
CADIAN CAPITAL MANAGEMENT, LP 5,517,767$26,540,0001.17%
NEEDHAM INVESTMENT MANAGEMENT LLC 1,590,000$7,646,0001.04%
Parkman Healthcare Partners LLC 420,000$2,020,0000.58%
Penn Capital Management Company, LLC 977,526$4,702,0000.49%
Bullseye Asset Management LLC 79,272$381,0000.37%
Bellevue Group AG 2,441,241$11,742,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,783$1,447,0000.18%
Granite Investment Partners, LLC 589,313$2,835,0000.13%
WRAPMANAGER INC 68,163$328,0000.10%
View complete list of GENMARK DIAGNOSTICS INC shareholders